| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1016460 |
| landingPage: |
http://www.iedb.org/assay/1898691 |
| type: |
Literature
|
| publicationVenue: |
Proc Natl Acad Sci U S A
|
| dates: |
2009
|
| study type: | b cell assays |
| subject species: |
| fullName: |
M Britschgi
C E Olin
H T Johns
Y
M C LeMieux
K Rufibach
J Rajadas
H Zhang
B Tomooka
W H Robinson
C M Clark
A M Fagan
D R Galasko
D M Holtzman
M Jutel
J A Kaye
C A Lemere
J Leszek
G Li
E R Peskind
J F Quinn
J A Yesavage
J A Ghiso
|
| method: |
microarray
|
| name: |
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.
|
| description: |
The natural epitope comprises aa1-22 [EASNCFAIRHFENKFAVETLIC].
By day 301 post-immunization, vervets developed a 370-fold median increase (range of 80- to 50,000-fold) in IgG antibodies to full-length beta amyloid preparations. Immunization with full-length beta amyloid not only increases immunity to select beta amyloid peptide species, but also triggers the expansion of cross-reactive antibodies against other known toxic amyloidogenic peptides. Reactivity to oligomeric forms of the epitope was greater.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |